No abstract available
MeSH terms
-
Algorithms
-
Animals
-
Binding, Competitive
-
Biomarkers, Tumor / analysis*
-
Clinical Trials, Phase I as Topic
-
Gastrointestinal Neoplasms / chemistry
-
Gastrointestinal Neoplasms / diagnostic imaging*
-
Gastrointestinal Neoplasms / metabolism
-
Gastrointestinal Neoplasms / therapy
-
Humans
-
Indium Radioisotopes* / pharmacokinetics
-
Indium Radioisotopes* / therapeutic use
-
Neoplasm Metastasis
-
Neoplasm Proteins / analysis*
-
Neoplasm Staging / methods*
-
Neuroendocrine Tumors / chemistry
-
Neuroendocrine Tumors / diagnostic imaging*
-
Neuroendocrine Tumors / metabolism
-
Neuroendocrine Tumors / therapy
-
Neuropeptides / metabolism
-
Octreotide / analogs & derivatives*
-
Octreotide / pharmacokinetics
-
Octreotide / therapeutic use
-
Pancreatic Neoplasms / chemistry
-
Pancreatic Neoplasms / diagnostic imaging*
-
Pancreatic Neoplasms / metabolism
-
Pancreatic Neoplasms / therapy
-
Pentetic Acid / analogs & derivatives*
-
Pentetic Acid / pharmacokinetics
-
Pentetic Acid / therapeutic use
-
Radiology, Interventional
-
Radionuclide Imaging / methods
-
Radiopharmaceuticals* / pharmacokinetics
-
Radiopharmaceuticals* / therapeutic use
-
Receptors, Somatostatin / analysis*
-
Sensitivity and Specificity
-
Somatostatin / chemistry
-
Somatostatin / physiology
Substances
-
Biomarkers, Tumor
-
Indium Radioisotopes
-
Neoplasm Proteins
-
Neuropeptides
-
Radiopharmaceuticals
-
Receptors, Somatostatin
-
SDZ 215-811
-
Somatostatin
-
Pentetic Acid
-
Octreotide